Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6014459

CCCCc1ccccn1.N

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.58
HRH3 Q9Y5N1 2/20 0.55
ALDH1A1 P00352 2/20 0.53
LMNA P02545 2/20 0.53
TAAR1 Q96RJ0 1/20 0.53
ALOX15 P16050 1/20 0.53
CYP1A2 P05177 4/20 0.50
CYP2C19 P33261 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HRH4 Q9H3N8 1/20 0.49
NAAA Q02083 1/20 0.49
KCNH2 Q12809 1/20 0.48
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL29039613 0.98 HRH1 (0.56) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL29582320 0.98 HRH1 (0.60) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL64052 0.98 HRH1 (0.60) HRH1HRH3ALDH1A1LMNATAAR1
Bromide SCHEMBL28377567 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL28143532 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1
Hydrochloric Acid SCHEMBL30395582 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1
Hydrochloric Acid SCHEMBL29039292 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1
Hydrochloric Acid SCHEMBL30887885 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1
Iodide SCHEMBL27863788 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1
Hydrochloric Acid SCHEMBL28142755 0.96 HRH1 (0.58) HRH1HRH3ALDH1A1LMNATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107473250-A It is a kind of to be used to purify additive of sodium aluminate solution and preparation method thereof 湖南诺兰蒂尔环保科技有限公司 2017-12-15 CN disclosed
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
EP-1442027-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-04 EP disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed
WO-2003031419-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 HRH1 1821/4885HRH3 3019/4885ALDH1A1 37/4885
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 HRH1 1821/4885HRH3 3019/4885ALDH1A1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.